Yaz/Yasmin/Ocella MDL transferred to Southern District of Illinois
The Judicial Panel of Multidistrict Litigation assigned the Yasmin And Yaz MDL to Judge David R. Herndon of the Southern District of Illinois. The Yaz/Yasmin/Ocella MDL, docket number 2100 was created for the purposes of consolidating all federal Yaz/Yasmin lawsuits alleging personal injury and wrongful death. The cases are now under the heading IN RE: Yasmin and Yaz (Drospirenone) Marketing and Sales Practices and Products Liability Litigation.
The Judicial Panel found the Southern District of Illinois will serve the convenience of the parties and witnesses and promote the just and efficient conduct of this litigation. U.S. District Court Judge David R. Herndon will preside over these Yaz and Yasmin cases for coordinated or consolidated pretrial proceedings. All consolidated actions share factual questions relating to at least one of the drospirenone-containing oral contraceptives Yaz and Yasmin, which are manufactured by Bayer. Plaintiffs in the products liability actions challenge the safety of those oral contraceptives and bring claims for personal injuries or wrongful death stemming from use of the drugs.
Yaz and Yasmin, as well as the generic Ocella, have been associated with various serious side effects, including Blood Clots, Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Stroke, Cerebrovascular Accidents (CVA), Heart Attack, Myocardial Infarction, Gallbladder Disease / Injury, Gallbladder Removal (cholecystectomy), Kidney Failure or Renal Failure, Pancreatitis and even Death.